Dr. Scott Tagawa, MD
Claim this profileWeill Cornell Medical College
Expert in Prostate Cancer
Studies Kidney Cancer
13 reported clinical trials
23 drugs studied
Area of expertise
1Prostate Cancer
Global LeaderStage IV
2Kidney Cancer
Stage IV
Stage III
TFE-3/B translocation positive
Affiliated Hospitals
Clinical Trials Scott Tagawa, MD is currently running
225Ac-J591 Re-treatment
for Prostate Cancer
This trial is testing a new drug, 225Ac-J591, which targets and kills prostate cancer cells using radiation. It is aimed at men with advanced prostate cancer that hasn't responded to other treatments. The drug combines a protein that finds cancer cells with a radioactive particle to destroy them. Researchers want to see if it can be given safely without severe side effects. 225Ac-J591 is a new development in PSMA-targeted radiotherapy, building on previous successes with similar treatments.
Recruiting1 award Phase < 110 criteria
ARX517 + Enzalutamide
for Prostate Cancer
This trial is testing ARX517, a new drug, in adults with advanced prostate cancer that doesn't respond to usual treatments. The study aims to see if the drug is safe and effective in stopping or slowing down cancer growth.
Recruiting1 award Phase 17 criteria
More about Scott Tagawa, MD
Clinical Trial Related3 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Scott Tagawa, MD has experience with
- 225Ac-J591
- Pembrolizumab
- ARX517
- Lenvatinib
- Research Blood Collection
- 177Lu-PSMA-617
Breakdown of trials Scott Tagawa, MD has run
Prostate Cancer
Kidney Cancer
Renal Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott Tagawa, MD specialize in?
Scott Tagawa, MD focuses on Prostate Cancer and Kidney Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Scott Tagawa, MD currently recruiting for clinical trials?
Yes, Scott Tagawa, MD is currently recruiting for 5 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Scott Tagawa, MD has studied deeply?
Yes, Scott Tagawa, MD has studied treatments such as 225Ac-J591, Pembrolizumab, ARX517.
What is the best way to schedule an appointment with Scott Tagawa, MD?
Apply for one of the trials that Scott Tagawa, MD is conducting.
What is the office address of Scott Tagawa, MD?
The office of Scott Tagawa, MD is located at: Weill Cornell Medical College, New York, New York 10065 United States. This is the address for their practice at the Weill Cornell Medical College.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.